Because cell culture is so labor-intensive, simply scaling up the number of growth chambers is not really a viable option for these investigators; instead they must look to entirely different cell ...

But scaling up will be challenging. “Bioreactors in which living cells ... with a research background in mammalian cell culture and a recent move into the marketplace as co-founder of cultivated ...

New Brunswick Scientific has introduced a benchtop cell culture bioreactor that combines the ... monitor makes it easy to set and monitor up to 32 process parameters and store up to ten recipes ...

We’re not trying to replace or even compete with agriculture; we're closing the gap between demand and supply," says the CEO ...

A fully-automated bioreactor ... up to three months. Key benefits include full automation and modularity of the bioreactor, and a novel impeller design that ensure homogeneity within the cell culture.

However, the conventional process of human NK cell expansion faces unique cell culture challenges for clinically relevant applications ... The potential of NK cells as an off-the-shelf therapy How to ...

The BioXplorer 5000 is a lab-scale bioreactor platform ... pressure during the culture. This enables understanding of pressure effects on the bioprocess prior to scaling up. Interchangeable ...

These bioreactors are simple in design and offer good heat and mass transfer characteristics. They are often used for processes that require high oxygen transfer rates. Fluidized bed bioreactors ...

Sensors inside the bioreactor monitor these parameters continuously in real time, ensuring homogeneity in the cell suspension culture, even with large quantities of cells. The glass vessel ...

Cell therapy production processes tend to evolve as the product moves through clinical development towards approval. While such changes may streamline testing, they can be a challenge when it ...

The biomanufacturing process for cell and gene therapies also benefits ... implementations completed in under three months, the bioreactor is primed for global deployment and underserved markets.